中文 | English
Return
Total: 4 , 1/1
Show Home Prev Next End page: GO
Author:(Guojia XU)

1.Drofenine as a Kv2.1 inhibitor alleviated AD-like pathology in mice through Aβ/Kv2.1/microglial NLRP3/neuronal Tau axis.

Jian LU ; Qian ZHOU ; Danyang ZHU ; Hongkuan SONG ; Guojia XIE ; Xuejian ZHAO ; Yujie HUANG ; Peng CAO ; Jiaying WANG ; Xu SHEN

Acta Pharmaceutica Sinica B 2025;15(1):371-391

2.Predictive Modeling of Chronic Kidney Disease with Hypertension or Diabetes Based on Machine Learning Algorithms

Huijuan ZENG ; Bo TIAN ; Hongling YUAN ; Jie HE ; Guanxi LI ; Guojia RU ; Min XU ; Dong ZHAN

Journal of Kunming Medical University 2024;45(3):99-105

3.Identification of In Vivo Metabolites of Tolvaptan in Rats

Guojia XU ; Xin JIANG ; Bin XIA ; Luqin SI ; Jiangeng HUANG ; Dan LI ; Yongjun ZHANG

Herald of Medicine 2023;42(12):1772-1779

4.Perioperative nursing care of elderly postlingual deafness patients with cochlear implantation

Ning WANG ; Xu YANG ; Xue GAO ; Guojia WANG

Chinese Journal of Modern Nursing 2015;21(28):3408-3410

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 4 , 1/1 Show Home Prev Next End page: GO